DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea · Delayed Price · Currency is KRW 14,960
-50 (-0.33%)
At close: Apr 29, 2026
DAE HWA Pharmaceutical Market Cap
DAE HWA Pharmaceutical has a market cap or net worth of 257.85 billion as of April 30, 2026. Its market cap has increased by 3.81% in one year.
Market Cap
257.85B
Enterprise Value
353.59B
Revenue
143.06B
Ranking
n/a
PE Ratio
156.60
Stock Price
14,960.00
Market Cap Chart
Since March 1, 2004, DAE HWA Pharmaceutical's market cap has increased from 15.67B to 257.85B, an increase of 1,545.66%. That is a compound annual growth rate of 13.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 257.85B | -15.55% |
| Dec 30, 2025 | 305.32B | 59.32% |
| Dec 30, 2024 | 191.63B | 16.63% |
| Dec 28, 2023 | 164.31B | -0.21% |
| Dec 29, 2022 | 164.66B | 0.86% |
| Dec 30, 2021 | 163.26B | -39.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 483.75B |
| HEM Pharma | 426.98B |
| NOVAREX | 258.45B |
| GREEN CROSS WellBeing | 246.48B |
| High Tech Pharm | 205.33B |
| Vivozon Pharmaceutical | 190.42B |
| OPTUS Pharmaceutical | 165.70B |
| Organoidsciences | 151.14B |